ASX:HLA

Healthia (HLA) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
155,400 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
2.23%
Price Target
N/A

About Healthia

Healthia Limited provides health services in Australia. It operates through three segments: Feet & Ankles; Bodies & Minds; and Eyes & Ears. The company operates podiatry and retail footwear; physiotherapy, hand therapy, occupational therapy, exercise physiology, and speech pathology clinics; and optometry and audiology stores, as well as manufactures and sells orthotic devices. It also offers foot care services, hand and upper limb therapies, orthopaedic, optometry, audiology, pilates, custom orthotic manufacturing services, and medical products to podiatrists, hospitals, medical centres, nursing homes, and allied health professionals. Healthia Limited was incorporated in 2018 and is based in Bowen Hills, Australia.

HLA Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com
Receive HLA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Healthia and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Medical Care Facilities
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Net Income
$5.47 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$252.56 million
Book Value
A$1.09 per share

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
1.02
Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Executives

  • Mr. Wesley James Coote ACIS
    B.Com., C.A., Group MD, CEO & Director
  • Mr. Damien Peters
    Group Chief Financial Officer
  • Mr. Darren Lindsey Stewart
    Director of Podiatry & Executive Director
  • Ms. Lisa Roach
    Group Chief Partnerships Officer & Executive Director
  • Mr. Colin Jonathan Kangisser
    CEO of Eyes & Ears Division and Director
  • Mr. Roy Walker
    Chief Executive Officer of Bodies, Minds, Feet & Ankles Division
  • Mr. Dean Hartley
    Chief Technology Officer
  • Ms. Julia Murfitt
    General Counsel & Company Secretary
  • Mr. Anthony Peter Ganter
    Group Chief Business Development & Strategy Officer
  • Dr. Kerrie Evans
    Group Chief Education & Research Officer

HLA Stock Analysis - Frequently Asked Questions

Is Healthia a good dividend stock?

Healthia (ASX:HLA) pays an annual dividend of A$0.04 per share and currently has a dividend yield of 2.23%. The dividend payout ratio is 80.00%. Payout ratios above 75% are not desirable because they may not be sustainable.
Read our dividend analysis for HLA.

This page (ASX:HLA) was last updated on 4/24/2024 by MarketBeat.com Staff

From Our Partners